Organigram Global Inc. · TSX:OGI

Organigram Global — Q3 2019 Earnings Presentation

21 slides from Organigram Global's earnings presentation, Jul 15, 2019

  1. Slide 1: Q3 Fiscal 2019 Results

    Q3 Fiscal 2019 Results July 15, 2019 NASDAQ (OGI) TSX Venture (OGI)

  2. Slide 2: Cautionary Statement

    Cautionary Statement This document is current as of July 14, 2019, except where otherwise stated. The information contained in this presentation is provided by Organigram ("OGI" or the “Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the so

  3. Slide 3: Q3 2019 Highlights

    Q3 2019 Highlights Strong Q3 operating and financial results Distribution in all 10 provinces; one of only 4 licensed producers Phase 4 expansion on schedule for expected completion by December 2019 for target production capacity of 113,000 kg per year? Phase 4A now fully licensed for 61,000 kg per

  4. Slide 4: Phase Expansion on Schedule

    Phase 4 Expansion on Schedule 113,000 KG/YR TARGET PRODUCTION CAPACITY a 24,000 KG/YR » With Phases 4A completed, current licensed UNDER 89,000 KG/YR CONSTRUCTION target production capacity is 61,000kg/yr' * Entire Phase 4 expected to be completed in December 2019 for total target production capacit

  5. Slide 5: Well-positioned for Edibles and Derivatives

    Well-positioned for Edibles and Derivatives THE (GREEN) Valen joer SOLUTION ° Exclusive agreement with The Green Immediate increased extraction Solution, a proven market leader in capacity from Valens GroWorks the US for consulting services re: product agreement and Phase 5 processing and developmen

  6. Slide 6: Cowen's THC Tracker: U.S. Brands

    6 1 QUICK TAKE - Cannabis - Cowen's THC Tracker: U.S. Brands - Cowen and Company, March 29, 2019

  7. Slide 7: Innovative Vaporizer Experiences

    Innovative Vaporizer Experiences PA> 0? * Selected as one of only four Canadian partners for PAX Era, ar the premium closed loop vaporizer system created by PAX Labs, Inc. * Pax Labs, Inc. - a leader in the design and development of m7 7. 2 premium app-controlled vape technologies for cannabis penne

  8. Slide 8: Investment in Innovative Chocolate

    Investment in Innovative Chocolate production line » $15 million investment commitment in a high-speed, high-capacity, fully-automated production line with capacity of up to 4 million kg of chocolate cannabis edibles per year * OGI product development and production team has more than 25 years of ch

  9. Slide 9: Proprietary Nano-Emulsification Technology

    Proprietary Nano-Emulsification Technology * Planning to launch dried powder formulation beverage products in early calendar 2020 in Canada * Proprietary nano-emulsion technology, developed by internal R&D team which created products with an expected initial onset of 10-15 minutes * Shelf-stable, th

  10. Slide 10: Phase 5 Refurbishment for Edibles and Derivative Products

    Phase 5 - Refurbishment for Edibles and Derivative Products * 56,000 square feet within existing Moncton Campus facility being refurbished and designed under EU GMP standards for: * An edibles and derivative production facility; and g z fa Fa g 2 Fa * Additional extraction capacity * Primary constru

  11. Slide 11: • Q3 net revenue from: • 3,926 kg of dried flower and 5,090 L

    • Q3 net revenue from: • Q3 adjusted gross margin impacted by • Q3 marks fourth quarter in a row of higher production costs, temporary • 3,926 kg of dried flower and 5,090 positive adjusted EBITDA decline in yields and write-offs of legacy L of oil sold packaging • Q3 SG&A3 at 37% of net revenue • $

  12. Slide 12: Q3 2019 and YTD Fiscal 2019 Metrics

    Q3 2019 and YTD Fiscal 2019 Metrics C$M unless otherwise indicated Q3 and YTD for 9 Months Ended May 31, 2019 Q3 YTD Q3 and 2018 Fiscal Year-End Q3 Aug 31, 2018 Net Revenue 24.8 64.1 Cash & Short Term Investments 87.8 130.0 Cost of Sales and Indirect Production 12.5 27.0 Inventories 94.2 45.0 Adjust

  13. Slide 13: Pre-rolls 7% & other

    • • • • Pre-rolls • 7% & other • • • 13

  14. Slide 14: Canadian, US and International Markets

    CANADIAN, US and INTERNATIONAL MARKETS • • • • • • • 14

  15. Slide 15: Appendix

    Appendix

  16. Slide 16: 16

    16 16

  17. Slide 17: Phase 4B Fit Up

    Phase 4B Fit Up

  18. Slide 18: Phase 4C Steel Being Erected

    Phase 4C Steel Being Erected

  19. Slide 19: 19

    19 19

  20. Slide 20: Fully Automated Labeling

    Fully Automated/Lakeling Raith and Excise Stam P APR cam

  21. Slide 21: 21

    21 21

Organigram Global — Q3 2019 Earnings Presentation on 6ix